Reuters - USMCA lacks provisions to change drug patent laws
)
The United States-Mexico-Canada Agreement has no provisions that would force changes to U.S. laws with respect to pharmaceutical companies U.S. Trade Representative Robert Lighthizer said on Tuesday. (ROUGH CUT-NO REPORTER NARRATION)
You may also like
